3,4-dihydroxyphenylacetaldehyde has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellen, HJ; Duraine, L; Goldstein, DS; Kao, CY; Lee, HJ; Lin, SC; Tsai, MJ; Tsai, SY; Wang, L; Xu, M | 1 |
| Bellen, HJ; Chen, R; D'Amelio, M; Gibbs, RA; Goldstein, DS; Graham, BH; Landrock, KK; Martini-Stoica, H; Stoica, G; Sullivan, P; Yamamoto, S | 1 |
| Fernandez, E; Goldstein, DS; Martinez, PA; Strong, R; Sullivan, P; Wey, MC | 1 |
| Burke, WJ; Li, SW; Nonneman, R; Williams, EA; Zahm, DS | 1 |
4 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and Disease Models, Animal
| Article | Year |
|---|---|
Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Brain; Cell Line; Cell Line, Tumor; Cohort Studies; COUP Transcription Factor II; Datasets as Topic; Disease Models, Animal; Disease Progression; Dopaminergic Neurons; Female; Humans; Male; Mice; Mice, Knockout; Mitochondria; Oxidative Stress; Parkinson Disease; Primary Cell Culture; Rats; RNA-Seq; Up-Regulation | 2020 |
Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Central Nervous System; Disease Models, Animal; Electron Transport Chain Complex Proteins; Heredodegenerative Disorders, Nervous System; Microscopy, Electron, Transmission; Mutation; Myosin Heavy Chains; Myosin Type V; Phosphorylation; Rats; Rats, Mutant Strains; tau Proteins | 2018 |
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase | 2012 |
3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Homovanillic Acid; Immunohistochemistry; Male; Neurons; Parkinson Disease; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2003 |